Literature DB >> 31899825

LncRNA FGD5-AS1 can be predicted as therapeutic target in oral cancer.

Longkun Liu1, Yuhua Zhan1, Yinwen Huang1, Luyao Huang2.   

Abstract

BACKGROUND: Long non-coding RNAs (lncRNAs) have been extensively studied to participate in the carcinogenesis of various tumors. LncRNA FGD5-AS1 has been studied as an oncogene in several cancers; however, the role it plays in oral squamous cell carcinoma (OSCC) still remains unclear.
METHODS: Quantitative real-time polymerase chain reaction (qRT-PCR) was used to assess relevant RNAs expression. CCK-8 and colony formation were combined to investigate cell proliferation. Flow cytometry was implemented to test the apoptosis of cell. Wound healing assay and transwell assays were conducted to investigate cell migration and invasion. Western blot assay was conducted to measure relevant protein expression.
RESULTS: FGD5-AS1 expression was aberrantly up-regulated in OSCC tissue and cells. FDG5-AS1 up-regulation induced USP21 overexpression advances OSCC development. Knockdown of FGD5-AS1 inhibited cell growth, migration, and invasion, yet promoted apoptosis.
CONCLUSION: FGD5-AS1 regulates OSCC via competitively binding to miR-520b against USP21. It could become a potential diagnostic biomarker for OSCC.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FGD5-AS1; USP21; cell proliferation; miR-520b; oral squamous cell carcinoma

Mesh:

Substances:

Year:  2020        PMID: 31899825     DOI: 10.1111/jop.12989

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  19 in total

1.  Expression and mechanism of long non-coding RNA HCG22 in oral squamous cell carcinoma.

Authors:  Yong Qiang Gao; Peng Wei Shi; Wen Kai Shi; Yi Ming Liu
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-12-01

2.  LncRNA FGD5-AS1 reduces cardiomyocyte apoptosis and inflammation by modulating Akt and miR-223-3p expression.

Authors:  Yu Zhao; Cuancuan Wang; Tiejun Cui; Qiaoyi Wang; Yingchun Xu; Chunbo Miao; Shaoyan Liu
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

3.  Long-Noncoding RNA FGD5-AS1 Enhances the Viability, Migration, and Invasion of Glioblastoma Cells by Regulating the miR-103a-3p/TPD52 Axis.

Authors:  Daoqing Su; Zhengang Ji; Pengfei Xue; Shengfu Guo; Qingbin Jia; Hanyu Sun
Journal:  Cancer Manag Res       Date:  2020-07-27       Impact factor: 3.989

4.  Long Non-coding RNA FGD5-AS1 Regulates Cancer Cell Proliferation and Chemoresistance in Gastric Cancer Through miR-153-3p/CITED2 Axis.

Authors:  Yunhan Gao; Mubing Xie; Yi Guo; Qian Yang; Song Hu; Zhongfu Li
Journal:  Front Genet       Date:  2020-08-11       Impact factor: 4.599

5.  FGD5-AS1 Inhibits Osteoarthritis Development by Modulating miR-302d-3p/TGFBR2 Axis.

Authors:  Yue Yang; Zhibo Sun; Feng Liu; Yuanzhang Bai; Fei Wu
Journal:  Cartilage       Date:  2021-04-09       Impact factor: 3.117

Review 6.  Non-Coding RNAs in Tuberculosis Epidemiology: Platforms and Approaches for Investigating the Genome's Dark Matter.

Authors:  Ahmad Almatroudi
Journal:  Int J Mol Sci       Date:  2022-04-17       Impact factor: 6.208

Review 7.  The role of long non-coding RNA FGD5-AS1 in cancer.

Authors:  Na He; Linbiao Xiang; Lei Chen; Haobin Tong; Keshen Wang; Jie Zhao; Feixue Song; Hanteng Yang; Xinyuan Wei; Zuoyi Jiao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 8.  Long Non-Coding RNAs as Functional Codes for Oral Cancer: Translational Potential, Progress and Promises.

Authors:  Cing-Syuan Lei; Hsing-Jien Kung; Jing-Wen Shih
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

9.  LncRNA FGD5-AS1 Facilitates the Radioresistance of Breast Cancer Cells by Enhancing MACC1 Expression Through Competitively Sponging miR-497-5p.

Authors:  Ji Li; Changjiang Lei; Bineng Chen; Qingfang Zhu
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

10.  LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer.

Authors:  Chao Ge; Jiali Dong; Yahui Chu; Sumin Cao; Jing Zhang; Jianming Wei
Journal:  Aging (Albany NY)       Date:  2020-07-16       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.